Amgen has invested nearly $2 billion in the U.S. over the last year, building on more than $40 billion invested in U.S. manufacturing and R&D since 2018. The TCJA, reinforced by the One Big Beautiful Bill Act, supports continued investment in domestic science and manufacturing.